Background: Few data are reported on the effects of a reduction of exposure to specific sensitizers in occupational asthma (OA). The objective of this study was to evaluate the clinical outcome of subjects with OA, comparing the effect of a reduction with that of the persistence or cessation of occupational exposure to the specific sensitizer. Subjects and Methods: Forty-one subjects with OA due to different sensitizers were diagnosed via a specific inhalation challenge. After a follow-up interval of 3.5 years, subjects were reexamined by clinical assessment, bronchial hyperresponsiveness (BH) and induced sputum. Results: At follow-up, subjects who had reduced occupational exposure (n = 22) showed a significant improvement in BH and a nonsignificant improvement in sputum eosinophilia (from 5.3 to 1.1%, n.s.), while subjects still exposed (n = 10) showed a significant decrease in FEV1. Subjects who ceased work (n = 9) showed a trend of improvement in BH and sputum eosinophilia. Logistic analysis showed that the major determinant of improvement in BH at follow-up was the severity of BH at diagnosis, with a minimal contribution from the duration of exposure and treatment with inhaled corticosteroids during follow-up; reduction of work exposure did not enter into any model. Conclusion: The reduction of occupational exposure could not be considered to be as effective as work cessation, which remained the best treatment for OA. However, it was not associated with a deterioration of FEV1 as observed in subjects with persistent exposure.

Keywords:
Occupational asthma, Specific sensitizer exposure, Bronchial hyperresponsiveness
1.
Mapp CE, Boschetto P, Maestrelli P, Fabbri L: Occupational asthma. Am J Respir Crit Care Med 2005;172:280–305.
2.
Tarlo SM, Balmes J, Balkisson R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J: Diagnosis and management of work-related asthma: American College of Chest Physician Consensus Statement. Chest 2008;134:1–41.
3.
Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P: Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007;62:147–152.
4.
Malo JL, Grezzo H: Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care 2004;169:1304–1307.
5.
Perfetti l, Cartier A, Ghezzo H, Gautrin D, Malo JL: Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: relevance of the length of the interval from cessation of exposure. Chest 1998;114:398–403.
6.
Cote J, Kennedy S, Chan-Yeung M: Outcome of patients with cedar asthma with continuous exposure. Am Rev Respir Dis 1990;141:373–376.
7.
Moscato G, Dellabianca A, Perfetti L, Brame B, Galdi E, Niniano R, Paggiaro PL: Occupational asthma: a longitudinal study on the clinical and socioeconomic outcome after diagnosis. Chest 1999;115:249–256.
8.
Saetta M, Maestrelli P, Turato G, Mapp CE, Dilani G, Pivirotto F, Fabbri LM, Di Stefano A: Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995;151:489–494.
9.
Maghni K, Lemiere C, Ghezzo H, Yuquan W, Malo JL: Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004;169:367–372.
10.
Pisati G, Baruffini A, Zedda S: Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Ind Med 1993;50:60–64.
11.
Merget R, Schulte A, Gebler A, Breitstadt, Kulzer R, Berndt ED, Baur X, Schultze-Werninghaus G: Outcome of occupational asthma due to platinum salts after transferral to low-exposure areas. Int Arch Occup Environ Health 1999;72:33–39.
12.
Vandenplas O, Jamart J, Delwiche JP, Evrard G, Larbanois A: Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J Allergy Clin Immunol 2002;109:125–130.
13.
Moscato G, Malo JL, Bernstein D: Diagnosing occupational asthma: how, how much, how far? Eur Respir J 2003;21:879–885.
14.
Bacci E, Paggiaro PL, Dente FL, Morelli MC, Talini D, Battaglia A, Giuntini C: Non-specific bronchial hyperresponsiveness induced by occupational exposure to different irritants. Clin Exp Allergy 1989;19:341–343.
15.
Paggiaro PL, Vagaggini B, Dente FL, Bacci E, Bancalari L, Carrara M, Di Franco A, Giannini D, Giuntini C: Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects. Chest 1993;103:1123–1128.
16.
Talini D, Benvenuti A, Carrara M, Vaghetti E, Martini LB, Paggiaro PL: Diagnosis of flour-induced occupational asthma in a cross-sectional study. Respir Med 2002;96:236–243.
17.
Bacci E, Cianchetti S, Paggiaro PL, Carnevali S, Bancalari L, Dente FL, Di Franco A, Giannini D, Vagaggini B, Giuntini C: Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy 1996;26:1395–1400.
18.
Grammer LC, Shaughnessy MA, Kenamore BD: Clinical and immunologic outcome of 42 individuals with trimellitic anhydride-induced immunologic lung disease after transfer to low exposure. Allergy Asthma Proc 2000;21:355–359.
19.
Padoan M, Pozzato V, Simoni M, Zedda L, Milan G, Bononi I, Piola C, Maestrelli P, Boschetto P, Mapp CE: Long-term follow-up of toluene diisocyanate-induced asthma. Eur Respir J 2003;21:637–640.
20.
Maestrelli P, De Marzo N, Saetta M, Boscaro M, Fabbri LM, Mapp CE: Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate. Am Rev Respir Dis 1993;148:407–412.
21.
Marabini A, Siracusa A, Stopponi R, Tacconi C, Abbritti G: Outcome of occupational asthma in patients with continuous exposure: a 3-year longitudinal study during pharmacologic treatment. Chest 2003;124:2372–2376.
22.
Girard F, Chaboillez S, Cartier A, Cotè J, Hargreave FE, Labrecque M, Malo JL, Tarlo SM, Lemiere C: An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 2004;170:845–850.
23.
Di Franco A, Vagaggini B, Bacci E, Bartoli ML, Cianchetti S, Carnevali S, Dente FL, Giannini D, Macchioni P, Ruocco L, Paggiaro PL: Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma. Respir Med 1998;92:550–557.
24.
Anees W, Huggins V, Pavord ID, Robertson AS, Burge DS: Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax 2002;57:231–236.
25.
Lemière C, Pizzichini MM, Balkissoon R, Clelland L, Efthimiadis A, O’Shaughnessy D, Dolovich J, Hargreave FE: Diagnosing occupational asthma: use of induced sputum. Eur Respir J 1999;13:482–488.
26.
Oasys and occupational asthma. www. occupationalasthma.com.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.